Transcription factors in autoimmune diseases

被引：28

作者：

Eggert, M

Klüter, A

Zettl, UK

Neeck, G

机构：

[1] Rostock Clin S, Dept Internal Med, D-18059 Rostock, Germany

[2] Rostock Clin S, Ctr Rheumatol, D-18059 Rostock, Germany

[3] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany

来源：

CURRENT PHARMACEUTICAL DESIGN | 2004年 / 10卷 / 23期

关键词：

diabetes type 1; glucocorticoids; multiple sclerosis; NF-kappa B; rheumatoid arthritis; transcription factors; therapy;

D O I：

10.2174/1381612043383593

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The analysis of the molecular basis of autoimmune diseases is currently under intense investigation. The identification of novel mechanisms underlying the pathogenesis of these diseases generates the possibility for the development of new therapeutic agents. In this review we summarize the results leading to novel insights concerning the molecular processes involved in the pathogenesis of rheumatoid arthritis, systemic lupus erythematodes, multiple sclerosis and diabetes type 1. We focus on the role of transcription factors such as nuclear factor kappa B, activator protein 1, peroxisome proliferator-activated receptor, vitamin D receptor and the glucocorticoid receptor that mediate pro- and anti-inflammatory effects and therefore represent direct or indirect targets for therapeutic intervention.

引用

页码：2787 / 2796

页数：10

共 121 条

[1]

Abe M, 1997, J RHEUMATOL, V24, P420

[2] Understanding autoimmune diabetes: insights from mouse models [J].

Adorini, L ;

Gregori, S ;

Harrison, LC .

TRENDS IN MOLECULAR MEDICINE, 2002, 8 (01) :31-38

[3] Heterogeneous requirement of IκB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis -: Implications for therapy [J].

Andreakos, E ;

Smith, C ;

Kiriakidis, S ;

Monaco, C ;

de Martin, R ;

Brennan, FM ;

Paleolog, E ;

Feldmann, M ;

Foxwell, BM .

ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1901-1912

[4]

Asahara H, 1995, BIOCHEM MOL BIOL INT, V37, P827

[5] Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium [J].

Asahara, H ;

Fujisawa, K ;

Kobata, T ;

Hasunuma, T ;

Maeda, T ;

Asanuma, M ;

Ogawa, N ;

Inoue, H ;

Sumida, T ;

Nishioka, K .

ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :912-918

[6] Gene expression profiles in human autoimmune disease [J].

Aune, TM ;

Maas, K ;

Moore, JH ;

Olsen, NJ .

CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (23) :1905-1917

[7]

Aupperle KR, 1999, J IMMUNOL, V163, P427

[8] NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes [J].

Aupperle, KR ;

Bennett, BL ;

Han, ZN ;

Boyle, DL ;

Manning, AM ;

Firestein, GS .

JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2705-2711

[9] GLUCOCORTICOID RECEPTOR-BETA, A POTENTIAL ENDOGENOUS INHIBITOR OF GLUCOCORTICOID ACTION IN HUMANS [J].

BAMBERGER, CM ;

BAMBERGER, AM ;

DECASTRO, M ;

CHROUSOS, GP .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2435-2441

[10] Diabetes-associated sustained activation of the transcription factor nuclear factor-κB [J].

Bierhaus, A ;

Schiekofer, S ;

Schwaninger, M ;

Andrassy, M ;

Humpert, PM ;

Chen, J ;

Hong, M ;

Luther, T ;

Henle, T ;

Klöting, I ;

Morcos, M ;

Hofmann, M ;

Tritschler, H ;

Weigle, B ;

Kasper, M ;

Smith, M ;

Perry, G ;

Schmidt, AM ;

Stern, DM ;

Häring, HU ;

Schleicher, E ;

Nawroth, PP .

DIABETES, 2001, 50 (12) :2792-2808

← 1 2 3 4 5 6 7 8 9 10 →